GSK’s Asthma Therapy Advair® Diskus® Shown to Be Comparably Safe
Asthma, News
GlaxoSmithKline plc (GSK) has published results from the AUSTRI (SAS115359) study designed to evaluate the safety profile of the combinatory therapy Advair® Diskus® in patients with asthma, and which showed non-inferiority against a ... Read more